Ablation-first research
on Indian listed companies.
Productized deep-dive research for family offices, boutique PMS, independent RIAs, and AMC research desks. 5-year OOS validated methodology. Published negative findings alongside positive.
An 8-month, 5-year OOS ablation study.
We studied Indian mid-cap momentum strategies across a complete 5-year out-of-sample window (2021-2025). The finding that reversed prior consensus: neither volatility-adjustment nor regime-gating adds alpha. The simplest variant — raw momentum — is the only one passing all 8 validation gates.
0.96
OOS Sharpe
2.05
Alpha t-stat
0.63
DSR
8/8
Validation gates
“Do Regime Filters Add Value? An Ablation Study of Volatility-Adjusted Momentum in Indian Mid-Cap Equities.” In submission to arXiv + SSRN · target journals: Pacific-Basin Finance Journal, Journal of Empirical Finance, Quantitative Finance.
From research framework to productized deep-dives.
Every report applies the same ablation-first methodology to individual Indian listed companies.
Point-in-time universe
Survivorship-bias-free data. No retrospective selection. Corporate-action adjusted (splits, bonuses, dividends, de-mergers).
Full factor decomposition
Market, size, momentum, value exposures. Distinguishes factor-driven returns from genuine idiosyncratic alpha.
Rigorous validation
Bootstrap CIs, Deflated Sharpe Ratio, Probabilistic Sharpe Ratio, walk-forward testing. Not backtest-flattered.
Ablation appendix
Every finding tested against its own inverse. How robust is the thesis? If it breaks under alternative specifications, we say so — with numbers.
Honest downside framing
What breaks this thesis? Explicit failure modes. When market regimes shift, what changes?
Methodology transparency
Every deliverable includes a methodology appendix. Code available on request. Reproducible.
Every engagement includes:
- PDF report (15-30 pages) with full methodology + code availability
- 1-hour analyst call to walk through findings + Q&A
- Data package (CSV / Parquet) for your own rerun
- Raw code / notebook on request (Python / R)
Buyers who value rigor over volume.
Family offices
Ablation-first second opinion on positions you're sizing up.
₹50K – ₹5L per report
Boutique PMS firms
Rigorous research to cite in client letters. 3-5 names per quarter.
₹1 – 3L per month
Multi-family offices
White-label research for HNI client briefings.
₹3 – 10L per month
Independent RIAs
Differentiated research without broker conflicts.
₹50K per report
AMC research desks
Supplementary methodology on names under coverage.
Case-by-case
See the methodology in action.
What a sample report covers
- Thesis (2-3 pages). The bull case, bear case, and why the market is mispricing one of them.
- Ablation analysis. The alternative hypotheses we tested and ruled out, with supporting data.
- Valuation framework. DCF + multiples + sensitivity tables. No black-box number.
- Contrarian findings (3-5). Things consensus research missed, with supporting primary data.
- Key risks. Regulatory, operational, management, with probability-weighted impact.
- Methodology appendix. Every claim reproducible. Code + data sources on request.
Delivery
2-3 weeks
First draft after brief intake
20-40 pages
Typical length with appendix
PDF + raw data
Shared Drive, methodology appendix included
Request a sample report brief. We'll share scope + methodology on a 20-min call, and if there's fit, ship a first draft in 2-3 weeks.
From ₹50K per report to enterprise white-label.
No self-serve checkout. Every engagement starts on a 20-min call. GST-compliant invoicing. Net 15 standard. Enterprise contracts signed directly with Koovis AI.
Get notified when WealthPilot Research opens for customers
Common questions.
Are you offering investment advice?+
No. We publish research. Readers make their own investment decisions. WealthPilot is explicitly a research product, not an advisory, execution, or fund management service.
Are you SEBI-registered?+
No. We do not require SEBI registration because we do not offer investment advice, portfolio management, or execution. Our reports are research deliverables. Users are responsible for their own investment decisions.
How long does a report take?+
Standard deep-dive: 2-3 weeks from engagement. Expedited: 1 week (+₹25K surcharge). Monthly retainers deliver on the 15th of each month.
Can I see your methodology in full?+
Yes. Our validated 5-year OOS ablation paper publishes to arXiv + SSRN in 2026 (target journal: Pacific-Basin Finance Journal). Full methodology appendix in every report. Code available on request.
Do you trade the strategies you research?+
No. Research-only firm. No execution, no proprietary positions, no performance promises.
How do you differ from broker research?+
Three ways: (1) no sell-side conflicts, (2) ablation-first methodology — every claim tested against alternatives, (3) honest negative results published alongside positive ones.
Is this Indian equities only?+
Indian mid-cap + select large-cap coverage is our primary focus. Other markets available on request at bespoke pricing.